)
Chiron Real Estate (XRN) investor relations material
Chiron Real Estate Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Leadership team expanded with experienced hires, including new CIO, COO, and Head of Seniors Housing, to support a strategic pivot toward seniors housing and portfolio repositioning.
Significant progress made on capital allocation, asset sales, and acquisitions, including the $249 million purchase of two luxury seniors housing communities and the sale of seven inpatient rehab facilities for $217 million, retaining a 15% JV interest.
Transition underway from outpatient medical assets to higher-returning healthcare real estate, especially seniors housing, with SHOP now representing 25% of the portfolio.
Originated mezzanine loans totaling $5.2 million for under-development medical facilities, both 100% pre-leased to investment-grade tenants.
Portfolio repositioning aligns with industry trends toward healthcare-focused real estate and operational excellence.
Financial highlights
Net income for Q2 2026 was $72.3 million, up from $0.6 million in the prior year, driven by a $71.9 million gain on property sales.
Core FFO for the quarter was $15.1 million ($1.04 per share and unit), down from $16.6 million ($1.14 per share and unit) in the prior year.
Annualized Cash NOI for Q2 2026 was $106.5 million; same-store cash NOI increased 0.8% year-over-year, or 1.7% excluding a one-time item.
Cash and cash equivalents and restricted cash increased to $12.9 million as of June 30, 2026.
GAAP-redefined FFO per share and unit was $0.88 for the quarter.
Outlook and guidance
SHOP segment expected to become a more significant contributor as newly acquired communities stabilize and additional acquisitions close.
Dividend reduced from $0.25 to $0.16 per share monthly to retain cash and accelerate the acquisition strategy.
Focus remains on acquiring stabilized seniors housing assets and recycling capital from outpatient medical sales, with a large pipeline of investment opportunities identified.
The Landing and Riviera communities are expected to deliver yields above 7% upon stabilization in 2H 2028.
Management expects to unlock embedded value through active capital recycling and disciplined investment criteria.
- Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing - $425M in senior housing acquisitions, $100M equity, and 36% dividend cut drive growth.XRN
Q1 2026 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 2025 - AFFO and FFO rose, occupancy remained high, and dividend was cut to support growth and stability.XRN
Q2 2025 - Q3 2024 featured resilient occupancy, lower net income, and active acquisitions amid market challenges.XRN
Q3 2024 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 2024 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 2025 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 2024
Next Chiron Real Estate earnings date
Next Chiron Real Estate earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage